Ategrity Specialty Insurance Co Holdings (FRA:A1Q) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:A1Q Ategrity Specialty Insurance Co Holdings FRA:A1Q
17 GF Score
Price €21.20
! 3 Warning Signs
View Full Analysis

What is Ategrity Specialty Insurance Co Holdings Research & Development?

Ategrity Specialty Insurance Co Holdings FRA:A1Q -1.85% 17 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:A1Q with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ategrity Specialty Insurance Co Holdings's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Ategrity Specialty Insurance Co Holdings  (FRA:A1Q) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ategrity Specialty Insurance Co Holdings Research & Development Related Terms

Ategrity Specialty Insurance Co Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Ategrity Specialty Insurance Co Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ategrity Specialty Insurance Co Holdings Research & Development Chart

Ategrity Specialty Insurance Co Holdings Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00

Ategrity Specialty Insurance Co Holdings Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:A1Q
17GF Score
Ategrity Specialty Insurance Co Holdings FRA:A1Q
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ategrity Specialty Insurance Co Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Ategrity Specialty Insurance Co Holdings (FRA:A1Q) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ategrity Specialty Insurance Co Holdings and its competitors.
Is Ategrity Specialty Insurance Co Holdings' Research & Development too high?
Ategrity Specialty Insurance Co Holdings' current Research & Development is €0.0 Mil. Overall, Ategrity Specialty Insurance Co Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ategrity Specialty Insurance Co Holdings' Research & Development compare to UVE and SAFT?
Ategrity Specialty Insurance Co Holdings' Research & Development of €0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ategrity Specialty Insurance Co Holdings and its competitors. Ategrity Specialty Insurance Co Holdings's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ategrity Specialty Insurance Co Holdings stock overvalued right now?
Ategrity Specialty Insurance Co Holdings (FRA:A1Q) has a current Research & Development of €0.0 Mil. The current Research & Development is €0.0 Mil. Ategrity Specialty Insurance Co Holdings' overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ategrity Specialty Insurance Co Holdings (FRA:A1Q), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ategrity Specialty Insurance Co Holdings Business Description

Other Exchanges ASIC:USA
Address 9 West 57th Street, 33rd Floor, New York, NY, USA, 10019
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.
17GF Score

Get the complete analysis for FRA:A1Q

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.20
Price